CN Patent

CN109414442B — 一种化合物的液体制剂

Assigned to Loxo Oncology Inc · Expires 2024-03-29 · 2y expired

What this patent protects

公开了(S)‑N‑(5‑((R)‑2‑(2,5‑二氟苯基)吡咯烷‑1‑基)‑吡唑并[1,5‑a]嘧啶‑3‑基)‑3‑羟基吡咯烷‑1‑甲酰胺、其药学上可接受的盐或其组合的液体制剂，以及该液体制剂在治疗疼痛、癌症、炎症和某些传染病中的用途。

USPTO Abstract

公开了(S)‑N‑(5‑((R)‑2‑(2,5‑二氟苯基)吡咯烷‑1‑基)‑吡唑并[1,5‑a]嘧啶‑3‑基)‑3‑羟基吡咯烷‑1‑甲酰胺、其药学上可接受的盐或其组合的液体制剂，以及该液体制剂在治疗疼痛、癌症、炎症和某些传染病中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN109414442B
Jurisdiction
CN
Classification
—
Expires
2024-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Loxo Oncology Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.